Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05202834 Completed - Healthy Clinical Trials

Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on Human Skin

Start date: July 15, 2021
Phase:
Study type: Observational

Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on human skin

NCT ID: NCT05191563 Completed - Healthy Clinical Trials

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.

Start date: July 31, 2021
Phase: Phase 1
Study type: Interventional

An Open-Label, Randomized, Single-Dose Crossover Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects

NCT ID: NCT05190133 Completed - Healthy Clinical Trials

Drug-drug Interaction Study Between UIC201601 and UIC201602

Start date: May 28, 2016
Phase: Phase 1
Study type: Interventional

An open-label, multiple-dosing, two-arms, one-sequence study to evaluate the safety and pharmacokinetics after co-administration of UIC201601 and UIC201602 in healthy male volunteers.

NCT ID: NCT05172414 Completed - Healthy Clinical Trials

A Novel Fecal Sample Collection Method for Metagenomic Analyses

Start date: January 2, 2020
Phase:
Study type: Observational

This is an open-label, one-arm, one-time-point pilot assessing the intra- and inter-group variation of gut microbiome collection methods and storage conditions using metagenomic sequencing for analysis. This study recruited 6 adult volunteers collecting 12 fecal samples from one bowel movement. Subjects were given detailed instructions as to collect and store feces samples into the 4 different collection and preservation methods and return samples for metagenomic analysis.

NCT ID: NCT05154409 Completed - Healthy Clinical Trials

Blood and Urine Sample Collection From Healthy Volunteers

Start date: February 22, 2021
Phase:
Study type: Observational

The aim of the study is to obtain blood and urine samples from healthy volunteers to serve as a healthy control group for cross-cohort comparisons.

NCT ID: NCT05146089 Completed - Healthy Clinical Trials

Reflex Responses to Intermittent Hypoxia in Humans: Mechanisms and Consequences

Start date: December 20, 2016
Phase: Early Phase 1
Study type: Interventional

The overall goal of this project is to better understand the effect of intermittent hypoxia (IH) on sympathetic neuronal discharge patterns in humans, as well as mechanisms that mediate persistent sympathoexcitation with IH.

NCT ID: NCT05136521 Completed - Healthy Clinical Trials

Bioavailability Study of 300 mg Trazodone Hydrochloride (New Polymer) vs. 300 mg Trazodone Hydrochloride (Contramid® Prolonged-release Tablets) Under Fasting Conditions

Start date: February 17, 2020
Phase: Phase 1
Study type: Interventional

This study was designed to investigate the bioequivalence of the test and reference products when administered as single oral doses in two consecutive study periods, under fasting conditions.

NCT ID: NCT05135793 Completed - Healthy Clinical Trials

Bioequivalence Study of Vonoprazan From Topoprazan 20 mg Tablets (Hikma Pharma, Egypt) Versus Takecab 20 mg Tablets (Takeda Pharmaceutical Co. Ltd., Japan)

Start date: January 19, 2021
Phase: Phase 1
Study type: Interventional

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Vonoprazan From Topoprazan 20 mg Tablets (Hikma Pharma, Egypt) Versus Takecab 20 mg Tablets (Takeda Pharmaceutical Co. Ltd., Japan)

NCT ID: NCT05132023 Completed - Healthy Clinical Trials

Bioequivalence Study of Empagliflozin & Metformin HCL From Empagliform 12.5/1000 mg F.C.T (Hikma Pharma, Egypt) and Synjardy 12.5/1000 mg F.C.T (Boehringer Ingelheim International GmbH, Germany)

Start date: March 26, 2019
Phase: Phase 1
Study type: Interventional

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Empagliflozin & Metformin HCL from Empagliform 12.5/1000 mg F.C.T (Hikma Pharma, Egypt) and Synjardy 12.5/1000 mg F.C.T (Boehringer Ingelheim International GmbH, Germany)

NCT ID: NCT05123820 Completed - Healthy Clinical Trials

Pharmacokinetics of Omeprazole and Midazolam When Co-administered With ACT-1014-6470

Start date: November 13, 2021
Phase: Phase 1
Study type: Interventional

A study on whether ACT-1014-6470 has an effect on how the body takes up, distributes and gets rid of omeprazole and midazolam in healthy male subjects